Date Filed | Type | Description |
07/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/30/2023 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Granted 75,000 options to buy
@ $0.575, valued at
$43.1k
|
|
01/31/2022 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Granted 400,000 options to buy
@ $1.53, valued at
$612k
|
|
01/29/2021 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Granted 500,000 options to buy
@ $3.15, valued at
$1.6M
|
|
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/24/2020 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Granted 350,000 options to buy
@ $1.46, valued at
$511k
|
|
06/18/2019 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Exercised 21,875 options to buy
@ $0 |
|
02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/03/2018 |
4/A
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Paid exercise price by delivering 9,281 shares
@ $3.76, valued at
$34.9k
|
|
06/18/2018 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Paid exercise price by delivering 9,306 shares
@ $3.76, valued at
$35k
Exercised 21,875 options to buy
@ $0 |
|
01/25/2018 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Granted 100,000 options to buy
@ $4.19, valued at
$419k
|
|
06/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/04/2017 |
4
| Anderson David Evander (Chief Scientific Officer) has filed a Form 4 on VBI Vaccines Inc/BC
Txns:
| Granted 20,000 options to buy
@ $3.79, valued at
$75.8k
|
|